Virginia House Bill 2008 (Prior Session Legislation)

---

Spectrum: Moderate Partisan Bill (Democrat 8-1)
Status: Engrossed on January 28 2021 - 50% progression, died in chamber
Action: 2021-02-05 - Continued to 2021 Sp. Sess. 1 in Commerce and Labor (15-Y 0-N)
Text: Latest bill text (Comm Sub) [HTML]

Health insurance; authorization of drug prescribed for the treatment of a mental disorder. Requires that any provider contract between a carrier and a participating health care provider with prescriptive authority, or its contracting agent, contain provisions that require, when a carrier has previously approved prior authorization for any drug prescribed for the treatment of a mental disorder listed in the most recent edition of the Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric Association, no additional prior authorization can be required if (i) the drug is a covered benefit, (ii) the prescription does not exceed the U.S. Food and Drug Administration-labeled dosages, (iii) the prescription has been continuously issued for no fewer than three months, and (iv) the prescriber performs an annual review of the patient to evaluate the drug's continued efficacy, changes in the patient's health status, and potential contraindications. The bill provides that this requirement does not prohibit a carrier from requiring prior authorization for any drug that is not listed on its prescription drug formulary at the time the initial prescription is issued. The bill also provides that such provider contracts contain provisions requiring a carrier to honor a prior authorization issued by the carrier for a drug regardless if the drug is removed from the carrier's prescription drug formulary after the initial prescription for that drug is issued. Health insurance; authorization of drug prescribed for the treatment of a mental disorder. Requires that any provider contract between a carrier and a participating health care provider with prescriptive authority, or its contracting agent, contain provisions that require, when a carrier has previously approved prior authorization for any drug prescribed for the treatment of a mental disorder listed in the most recent edition of the Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric Association, no additional prior authorization can be required if (i) the drug is a covered benefit, (ii) the prescription does not exceed the U.S. Food and Drug Administration-labeled dosages, (iii) the prescription has been continuously issued for no fewer than three months, and (iv) the prescriber performs an annual review of the patient to evaluate the drug's continued efficacy, changes in the patient's health status, and potential contraindications. The bill provides that this requirement does not prohibit a carrier from requiring prior authorization for any drug that is not listed on its prescription drug formulary at the time the initial prescription is issued. The bill also provides that such provider contracts contain provisions requiring a carrier to honor a prior authorization issued by the carrier for a drug regardless if the drug is removed from the carrier's prescription drug formulary after the initial prescription for that drug is issued.

Health insurance; authorization of drug prescribed for the treatment of a mental disorder.

Del. Steve Heretick [D]	Del. Glenn Davis [R]	Del. Dawn Adams [D]	Del. Dan Helmer [D]
Del. Kaye Kory [D]	Del. Mark Levine [D]	Del. David Reid [D]	Del. Ibraheem Samirah [D]
Del. Marcus Simon [D]

2021-02-05 - Senate - Senate: Continued to 2021 Sp. Sess. 1 in Commerce and Labor (15-Y 0-N) (Y: 15 N: 0 NV: 0 Abs: 0) [PASS]
2021-01-29 - House - House: VOTE: Block Vote Passage (99-Y 0-N) (Y: 99 N: 0 NV: 0 Abs: 0) [PASS]
2021-01-26 - House - House: Reported from Labor and Commerce with substitute (22-Y 0-N) (Y: 22 N: 0 NV: 0 Abs: 0) [PASS]
2021-01-21 - House - House: Subcommittee recommends reporting with substitute (8-Y 0-N) (Y: 8 N: 0 NV: 0 Abs: 0) [PASS]
2021-01-21 - House - House: Subcommittee recommends reporting with substitute (8-Y 0-N) (Y: 8 N: 0 NV: 0 Abs: 0) [PASS]

Date	Chamber	Action
2021-02-05	Senate	Continued to 2021 Sp. Sess. 1 in Commerce and Labor (15-Y 0-N)
2021-02-01	Senate	Referred to Committee on Commerce and Labor
2021-02-01	Senate	Constitutional reading dispensed
2021-01-29	House	VOTE: Block Vote Passage (99-Y 0-N)
2021-01-29	House	Read third time and passed House BLOCK VOTE (99-Y 0-N)
2021-01-28	House	Engrossed by House - committee substitute HB2008H1
2021-01-28	House	Committee substitute agreed to 21103490D-H1
2021-01-28	House	Read second time
2021-01-27	House	Read first time
2021-01-26	House	Committee substitute printed 21103490D-H1
2021-01-26	House	Reported from Labor and Commerce with substitute (22-Y 0-N)
2021-01-21	House	Subcommittee recommends reporting with substitute (8-Y 0-N)
2021-01-14	House	Assigned L & C sub: Subcommittee #2
2021-01-11	House	Referred to Committee on Labor and Commerce
2021-01-11	House	Prefiled and ordered printed; offered 01/13/21 21101077D

HB2008 (Carry Over) 2021-02-05 - Continued to 2021 Sp. Sess. 1 in Commerce and Labor (15-Y 0-N)

Chapter	Article	Section	Citation Type	Statute Text
38	2	3407.15:2	(n/a)	See Bill Text

Type	Source
Summary	https://lis.virginia.gov/cgi-bin/legp604.exe?211+sum+HB2008
Text	https://lis.virginia.gov/cgi-bin/legp604.exe?211+ful+HB2008+hil
Text	https://lis.virginia.gov/cgi-bin/legp604.exe?211+ful+HB2008H1+hil
Amendment	https://committees.lis.virginia.gov/pdfs/drafts/21103490D.pdf
Supplement	https://lis.virginia.gov/cgi-bin/legp604.exe?211+oth+HB2008F122+PDF
Supplement	https://lis.virginia.gov/cgi-bin/legp604.exe?211+oth+HB2008FH1122+PDF
Roll Call	https://lis.virginia.gov/cgi-bin/legp604.exe?211+vot+H1402V0005+HB2008
Roll Call	https://lis.virginia.gov/cgi-bin/legp604.exe?211+vot+H1402V0008+HB2008
Roll Call	https://lis.virginia.gov/cgi-bin/legp604.exe?211+vot+H14V0056+HB2008
Roll Call	https://lis.virginia.gov/cgi-bin/legp604.exe?211+vot+HV1246+HB2008
Roll Call	https://lis.virginia.gov/cgi-bin/legp604.exe?211+vot+S02V0055+HB2008